[1]
Yusupov, A.F. et al. 2024. The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration. Journal of Ophthalmology (Ukraine). 3 (Jul. 2024), 28–32. DOI:https://doi.org/10.31288/oftalmolzh202432832.